[#DIV28SUPER] NIDA Neuroscience Update, August 16, 2022

Table of Contents:

I.                    Early Career Investigator Showcases Applications (NIDA-NIAAA Frontiers in Addiction Research Mini-Convention)

II.                  NIDA Racial Equity Initiative (NIDA REI)

-------

 

 

I.                  Early Career Investigator Showcases Applications (NIDA-NIAAA Frontiers in Addiction Research Mini-Convention)

 

Call For Applications. The 2022 NIDA-NIAAA Frontiers in Addiction Research Mini-Convention calls for applications for the Early Career Investigator Showcases (ECIS). The ECIS symposium provides a forum for scientific presentations by premier young and junior investigators working in the fields of alcohol and substance abuse and addiction research. This symposium will take place on Tuesday and Wednesday, November 1-2, 2022, during the Annual NIDA-NIAAA Frontiers in Addiction Research Mini-Convention. To apply, please complete the application form, include your Curriculum Vitae/Resume and list of publications, and send via email to (ECIS.Abstracts@seiservices.com) by Friday, September 2, 2022, 5:00 PM (EDT).

 

For additional information, please contact: for NIDA [Anne Tsai, stsai@nih.gov] or for NIAAA [John Matochik, jmatochi@mail.nih.gov]

 

II.               NIDA Racial Equity Initiative (NIDA REI)

 

New Funding Opportunity Announcements (FOAs) have been released by NIDA and the NIDA Racial Equity Initiative (NIDA REI). These FOAs are focused on research to advance equity for racial and/or ethnic minority populations in the United States. The FOAs call for innovative, solution-oriented, community-engaged research from research teams with a commitment to broad dissemination of findings. Applications are expected to incorporate diverse perspectives and all types of institutions are strongly encouraged to apply.

 

There will also be a webinar on September 26, 2022 at 3:00pm ET during which NIDA staff will provide an overview of the FOAs and respond to questions. Registration details for the webinar will be posted on the NIDA REI website.

 

Please reach out to the NIDA staff listed on the FOAs with questions!

 

Coordination Center. Single receipt date of November 15, 2022

RFA-DA-23-025: NIDA REI: Coordination Center to Support Racial Equity and Substance Use Disparities Research (U24 Clinical Trial Not Allowed) (nih.gov)

 

HIV and Substance Use. Multiple receipt dates. First due date of November 14, 2022.

RFA-DA-23-024: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R34 Clinical Trial Optional) (nih.gov)

RFA-DA-23-023: NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial/Ethnic Populations (R01 Clinical Trial Optional) (nih.gov)

 

Community Engaged R01 Projects. Multiple receipt dates. First due date of November 14, 2022.

RFA-DA-23-013: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional) (nih.gov)

RFA-DA-23-032: NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)

 

Racial Equity Visionary Award Program. Multiple receipt dates. First due date of November 14, 2022.

RFA-DA-23-026: NIDA REI: Racial Equity Visionary Award Program for Research on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (nih.gov)

RFA-DA-23-031: NIDA REI: Racial Equity Visionary Award Program for Research at Minority Serving Institutions on Substance Use and Racial Equity (DP1 Clinical Trial Optional) (nih.gov)

 

Neurocognitive Mechanisms. Multiple receipt dates. First due date of November 14, 2022.

RFA-DA-23-028: NIDA REI: Research on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)

RFA-DA-23-029: NIDA REI: Research at Minority Serving Institutions on Neurocognitive Mechanisms Underlying the Impact of Structural Racism on the Substance Use Trajectory (R61/R33 Clinical Trial Optional) (nih.gov)

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L